A Study of Ad26.COV2.S in Adults (COVID-19)
Clinical trial NCT04509947 · COMPLETED
Trial details
- NCT number
- NCT04509947
- Sponsor
- Janssen Pharmaceutical K.K.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-11
- Primary completion
- 2021-02-22
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.